Search clinical trials for: PSMA PET/CT

Total 9007 results

University of Alabama at Birmingham

Withdrawn

Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study

Acute Decompensated Heart Failure

United States
British Columbia Cancer Agency

Active, not recruiting

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Canada
Sun Yat-sen University

Completed

Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

Nasopharyngeal Carcinoma

China
The First Affiliated Hospital of Xiamen University

Unknown

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

Lung Adenocarcinoma | PET/CT | 18F-FDG | 68Ga-FAPI

China
University Health Network, Toronto

Completed

Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases

Colorectal Cancer | Liver Metastases

Canada
Aposense Ltd.

Completed

18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

Solid Tumors | Brain Metastases
Dallas VA Medical Center

Terminated

Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

Solid Tumors | Cancer Recurrence

United States
British Columbia Cancer Agency

Not yet recruiting

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Multiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma

Canada
Boston Children's Hospital
National Institutes of Health (NIH)

Enrolling by invitation

Pain in Fibrous Dysplasia

Fibrous Dysplasia/McCune-Albright Syndrome

United States
Affiliated Cancer Hospital & Institute of Guangzhou...

Not yet recruiting

18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer (FAPI-VTC)

Cancer
Celal Bayar University

Completed

The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

Breast Cancer

Turkey
University Medical Center Groningen

Completed

AR and ER Imaging in Metastatic Breast Cancer

Metastatic Breast Cancer

Netherlands
Mayo Clinic

Completed

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Hepatocellular Carcinoma

United States
Stanford University

Recruiting

Pediatric PET/MR Image Registry

Lymphoma | Osteosarcoma | Soft Tissue

United States
University Hospital, Antwerp
Universiteit Antwerpen

Recruiting

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Neuroendocrine Tumors

Belgium, Cyprus
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Invasive Breast Lobular Carcinoma | Metastatic Breast Lobular Carcinoma

United States
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
UMC Utrecht

Recruiting

68Ga PET/CT Versus 99mTc SPECT/CT for Lung Perfusion and Ventilation Scintigraphy; a Technical and Practical Feasibility Study (GaTcha)

Pulmonary Embolism | Ventilation Perfusion Mismatch

Netherlands
Jinling Hospital, China

Not yet recruiting

To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT (18F-LNC1007)

Tumour
GlaxoSmithKline
Quintiles, Inc.

Completed

A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts

Autoimmune Diseases

United Kingdom
University of California, San Francisco

Terminated

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

Thyroid Gland Carcinoma

United States
Hospices Civils de Lyon

Completed

Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study (PSMA)

Prostate Cancer

France
Huashan Hospital

Recruiting

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Kidney Cancer | Positron Emission Tomography | Lymphomas

China
Institut Cancerologie de l'Ouest

Active, not recruiting

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer (TEP-FES)

Metastatic Breast Cancer

France
University Hospital, Ghent
XEOS Medical

Completed

Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT

Head and Neck Neoplasms | Thyroid Neoplasm | Skin Neoplasm

Belgium
Rambam Health Care Campus

Completed

The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia (PETCT4SAB)

Staphylococcus Aureus Bacteremia

Israel
M.D. Anderson Cancer Center

Withdrawn

Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma

Lymphoma | Mantle Cell Lymphoma
Radboud University Medical Center

Unknown

Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.

Head and Neck Cancer

Netherlands
Rigshospitalet, Denmark

Withdrawn

New Indications for Ultrasound in the Staging of Cervical Cancer

Cervical Cancer

Denmark
Jonsson Comprehensive Cancer Center
Janssen Scientific Affairs, LLC

Recruiting

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial (HEATWAVE)

Prostate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8

United States
Sun Yat-sen University

Completed

Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy

Non-small Cell Lung Cancer

China
Imperial College London
Biogen; Invicro

Completed

TSPO PET as a Measure of Post-stroke Brain Inflammation: a Natural History Cohort

Inflammatory Response | Stroke, Ischemic | Stroke, Acute

United Kingdom
Jonsson Comprehensive Cancer Center

No longer available

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Neuroendocrine Tumors | Medullary Thyroid Cancer | Carcinoid Cancer | Cancers Expressing Somatostatin Receptors

United States
University Hospital, Antwerp
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) (ECLYPS)

Locally Advanced Squamous Cell Carcinoma of the Head and Neck Region

Belgium, Netherlands
University of Edinburgh
Chief Scientist Office of the Scottish Government

Completed

Sodium Fluoride Imaging of Abdominal Aortic Aneurysms (SoFIA3)

Abdominal Aortic Aneurysm

United Kingdom
Rigshospitalet, Denmark

Unknown

uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer

Neoplasms | Neoplasms by Site | Head and Neck Neoplasms | Oral Cancer | Oropharyngeal Cancer | Cancer of Mouth

Denmark
Miami Cancer Research Center, Inc.

Recruiting

I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

Thyroid Cancer | RAI-Refractory Thyroid Cancer

United States
ABSCINT NV/SA

Not yet recruiting

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer

Belgium
University of Texas Southwestern Medical Center
RefleXion Medical

Not yet recruiting

Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

Prostate Cancer
Semmelweis University Heart and Vascular Center
Semmelweis University Department of Pulmonology; Semmelweis University Medical...

Recruiting

COvid iMaging With POSitron Emission Tomography (COMPOSIT)

Coronavirus Infection

Hungary
Central Hospital, Nancy, France

Recruiting

Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas (DORA)

High Grade Glioma

France
Abramson Cancer Center of the University of Pennsylvania

Terminated

Early FDG PET in Melanoma

Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma

United States
University Hospital, Toulouse

Completed

Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT (AzoPredHisto)

Fertility

France
University of California, Davis

Completed

A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone (PETCT)

Normal Subjects

United States
Odense University Hospital

Completed

Evaluation of Preoperative Investigations in Patients With Liver Cancer

Primary Liver Cancer | Liver Metastasis

Denmark
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Biochemically Recurrent Prostate Carcinoma

United States
The Christie NHS Foundation Trust

Recruiting

Introduction of Y90-PET-CT Post Radioembolisation Therapy Scans (Y90-PET-CT)

Cancer

United Kingdom
Andrei Iagaru
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Prostate Cancer

United States
Wuhan Union Hospital, China

Recruiting

Clinical Application of Fibroblast Activation Protein PET/MRI in Liver Fibrosis

Magnetic Resonance Imaging | Liver Fibrosis | Positron Emission Tomography

China
Chinese PLA General Hospital

Unknown

Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer

Gastric Cancer Stage

Search clinical trials for: PSMA PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations